Short answer: yes — there are several important risks and side effects to be aware of before starting testosterone replacement therapy (TRT) in your 30s, and the biggest issues for many men are loss of fertility and testicular shrinkage. TRT can help symptoms of true hypogonadism, but it isn’t risk-free and should only be started after proper evaluation and monitoring. Key risks and side effects Fertility suppression and infertility Exogenous testosterone suppresses the hypothalamic‑pituitary‑gonadal axis → lower LH/FSH → decreased intratesticular testosterone and spermatogenesis. Sperm count can fall dramatically and infertility can be prolonged; recovery often takes months to years and is not guaranteed. If you plan to have children, discuss alternatives or sperm banking first. Testicular atrophy Testes commonly shrink because they produce less sperm and testosterone. Erythrocytosis (high red blood cell mass) TRT commonly raises hemoglobin/hematocrit; high hematocrit increases risk of blood clots, stroke, and heart attack. Regular CBC monitoring is required. Dose or formulation changes or phlebotomy may be needed. Cardiovascular risk (controversial) Data are mixed. Some studies show no increase in events; others suggest elevated risk in certain populations. Patients with uncontrolled cardiovascular disease need careful evaluation. Prostate issues TRT can increase PSA and may worsen benign prostatic hyperplasia (BPH) symptoms. Current evidence does not prove TRT causes prostate cancer, but baseline PSA and follow‑up testing are standard; TRT is contraindicated with active prostate or breast cancer. Mood and behavior changes Many experience improved mood and libido, but some report irritability, aggression, or mood swings — especially with peaks/troughs from injections. Sleep apnea TRT can worsen obstructive sleep apnea or unmask it. Skin, hair, and breast effects Acne, oily skin, and male pattern hair loss can worsen. Gynecomastia can occur because testosterone aromatizes to estradiol. Fluid retention and edema Can exacerbate heart failure or hypertension in susceptible people. Liver effects Oral 17‑alkylated androgens (rarely used medically) can be hepatotoxic. Modern testosterone gels/injections are usually not hepatotoxic but LFT monitoring may still be considered. Local reactions and transfer risk Injections can cause pain/irritation. Topical gels risk transferring testosterone to partners/children; careful application and hygiene are required. Nasal and injected options have different profiles. Who should not start TRT (common contraindications) Active breast or prostate cancer Uncontrolled erythrocytosis (hematocrit >50%) Unstable or poorly controlled heart failure or recent major cardiovascular events (needs specialist evaluation) Untreated severe sleep apnea Desire for immediate fertility (unless alternative strategies used) Monitoring and baseline tests (what your clinician should do) Confirm low testosterone on at least two morning total testosterone tests (and free testosterone if indicated) Measure LH/FSH, prolactin, SHBG if secondary hypogonadism suspected Baseline CBC (hematocrit/hemoglobin), PSA, lipid panel, liver function, CMP Evaluate cardiovascular risk, sleep apnea, and fertility desires Ongoing monitoring: testosterone levels, CBC at 3 months then periodically, PSA per guidelines, clinical assessment of symptoms/side effects If you want children: alternatives and precautions Consider sperm banking before starting TRT. Alternatives that preserve fertility: clomiphene citrate (Clomid) or hCG (brands: Pregnyl, Ovidrel/Novarel are forms of hCG) — these stimulate endogenous testosterone and spermatogenesis and are commonly used in men wanting to maintain fertility. For men with hypogonadism who also want fertility, a reproductive endocrinologist or reproductive urologist can design treatment. Formulation considerations (some pros/cons) Injectable testosterone (testosterone cypionate/enanthate): inexpensive, familiar; can cause peaks/troughs and mood swings. Long‑acting injections (testosterone undecanoate; Aveed, Nebido): less frequent dosing, steadier levels. Gels (AndroGel, Testim): steady daily dosing but risk of transfer to others. Nasal (Natesto): short‑acting, less risk of transfer; may require multiple daily doses. Pellets (Testopel): long‑lasting subcutaneous implants; requires minor office procedure. Practical recommendations Don’t start TRT without a full workup and clear indication (symptoms + confirmed low labs). If you’re in your 30s and plan to have kids, talk about sperm banking and discuss fertility‑sparing treatment options first. Choose an experienced prescriber (endocrinologist, urologist, or reproductive specialist) and follow monitoring plans closely. Address reversible causes of low testosterone first (weight loss, sleep apnea treatment, alcohol reduction, medications, and thyroid disease). Where to get evaluated and services to consider (examples) Specialty care: a reproductive urologist or endocrinologist at established centers (e.g., Mayo Clinic, Cleveland Clinic) for complex cases or fertility concerns. Routine labs: LabCorp or Quest Diagnostics for blood testing. Sperm banking: Cryos International or Fairfax Cryobank for fertility preservation services. Telemedicine TRT services (for convenience, but use cautiously): Hims, Roman, or Ro — they provide remote evaluation and prescriptions but don’t replace in‑person specialist care when fertility or complex medical issues are at stake. When to seek urgent care Sudden chest pain, shortness of breath, signs of stroke Very rapid swelling/edema or markedly increased blood pressure Any signs of a blood clot (leg pain/swelling) If you want, I can: List the specific baseline tests and a suggested monitoring schedule your clinician should follow. Compare formulations (injection vs gel vs nasal) and which might fit your lifestyle or fertility goals. Help draft questions to bring to your doctor. Would you like a monitoring checklist or help comparing formulations based on your priorities (fertility, convenience, cost, steady levels)?
Mentioned in position 15 of 19
Read full answer with sources →